This #WorldTBDay, catch up on findings from two 2018 studies on #tuberculosis that can help help track disease history and inform future therapies to #EndTB. 📄: https://t.co/CCzNmMRXog 📄: https://t.co/l1xlZKuMyZ https://t.co/tPIuaXWEjK
RT @casanova_lab: 5/ In the same issue of @SciImmunology, we reported that homozygosity for P1104A TYK2 selectively impairs cellular respon…
RT @casanova_lab: 5/ In the same issue of @SciImmunology, we reported that homozygosity for P1104A TYK2 selectively impairs cellular respon…
5/ In the same issue of @SciImmunology, we reported that homozygosity for P1104A TYK2 selectively impairs cellular responses to IL-23 and underlies mycobacterial disease (https://t.co/gCkPhcm4fU).